Persyst
further, Treatment Concepts for Alzheimer’s Disease
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
TPS in patients with Alzheimer`s disease
Prof. Dr Roland Beisteiner from Medical University Vienna delves into the latest science on Transcranial Pulse Stimulation (TPS) with NEUROLITH® system, the research behind it, his work and the success to date. This new technique allows unprecedented focal neuronal tissue stimulation reaching depths of as much as 8 cm in the brain and reflects an unparalleled advancement in the field of transcranial stimulation.
Transcranial Pulse Stimulation (TPS): first NEUROLITH system installed in Switzerland
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment
Recording of session »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« by Dr Pavel Novak Due to the high demand at Dementia 2021 virtual meeting Dr Pavel Novak has agreed to offer his lecture on the topic »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« for STORZ MEDICAL partners.
Applications of focused ultrasound in the brain; Nature Reviews Neurology
The past 5 years have seen a surge in innovation and global productivity in FUS clinical efforts, with the demonstration of a favourable safety profile as well as versatility across and scalability within several clinical indications. Following regulatory approval of MRgFUS thalamotomy for ET and tremor-dominant PD, thermoablation has gone from experimental treatment to standard of care. Efficacy data for drug delivery via FUS BBBO are anticipated over the next 2 years, probably within the neuro-oncology field initially. Additionally, a growing number of registered trials are addressing the application of FUS neuromodulation in epilepsy, AD, PD, depression and traumatic brain injury.
Virtual Alzheimers`s Disease International Conference, 10 – 12 December 2020
Join Dr Pavel Novak's oral presentation on »Transcraniel Pulse Stimulation - TPS reduces significantly the Alzheimer’s Disease Symptoms« during session OS06: Other syndromes and new and future treatments«.
Transcranial Pulse Stimulation in patients with Alzheimer‘s disease« by Prof. Roland Beisteiner
Watch the session »State of the Art of New Brain Stimulation Techniques« with Prof. Roland Beisteiner who presented on Transcranial Pulse Stimulation in patients with Alzheimer‘s disease on 12 November 2020.
further, Treatment Concepts for Alzheimer’s Disease
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
Transcranial Pulse Stimulation (TPS): first NEUROLITH system installed in Switzerland
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
Transcranial Pulse Stimulation (TPS): first NEUROLITH system installed in Switzerland
Transcranial Pulse Stimulation (TPS®) for the treatment of Alzheimer's patients is now also available for patients in Switzerland. In early February 2021, the first NEUROLITH® system was successfully installed in the Praxis Alexander Russ in Zurich.
Transcranial Pulse Stimulation in patients with Alzheimer‘s disease« by Prof. Roland Beisteiner
Watch the session »State of the Art of New Brain Stimulation Techniques« with Prof. Roland Beisteiner who presented on Transcranial Pulse Stimulation in patients with Alzheimer‘s disease on 12 November 2020.
further, Treatment Concepts for Alzheimer’s Disease
There are various forms of brain stimulation, that are used in neurodegenerative disease. In this webinar neurologist Dr Lars Wojtecki talks about scientific background and clinical data of Transcranial Pulse Stimulation as well as practical experience with handling and clinical effects. Which patient to choose? How does TPS compare to TMS?
TPS in patients with Alzheimer`s disease
Prof. Dr Roland Beisteiner from Medical University Vienna delves into the latest science on Transcranial Pulse Stimulation (TPS) with NEUROLITH® system, the research behind it, his work and the success to date. This new technique allows unprecedented focal neuronal tissue stimulation reaching depths of as much as 8 cm in the brain and reflects an unparalleled advancement in the field of transcranial stimulation.
Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment
Recording of session »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« by Dr Pavel Novak Due to the high demand at Dementia 2021 virtual meeting Dr Pavel Novak has agreed to offer his lecture on the topic »Brain Stimulation with Shockwaves (TPS) for Alzheimer’s Disease Treatment« for STORZ MEDICAL partners.
Virtual Alzheimers`s Disease International Conference, 10 – 12 December 2020
Join Dr Pavel Novak's oral presentation on »Transcraniel Pulse Stimulation - TPS reduces significantly the Alzheimer’s Disease Symptoms« during session OS06: Other syndromes and new and future treatments«.
Applications of focused ultrasound in the brain; Nature Reviews Neurology
The past 5 years have seen a surge in innovation and global productivity in FUS clinical efforts, with the demonstration of a favourable safety profile as well as versatility across and scalability within several clinical indications. Following regulatory approval of MRgFUS thalamotomy for ET and tremor-dominant PD, thermoablation has gone from experimental treatment to standard of care. Efficacy data for drug delivery via FUS BBBO are anticipated over the next 2 years, probably within the neuro-oncology field initially. Additionally, a growing number of registered trials are addressing the application of FUS neuromodulation in epilepsy, AD, PD, depression and traumatic brain injury.
We provide solutions for healthcare and research. We distribute medical equipment, provide scientific expertise and support to researcher